Quinethazone is a member of the class of quinazolines that is quinazolin-4-one substituted at positions 2, 6 and 7 by ethyl, sulfamoyl and chloro groups respectively; a thiazide-like diuretic used to treat hypertension. Among its listed roles, it functions as a diuretic and an antihypertensive agent. Quinethazone, marketed as Hydromox, is a thiazide diuretic indicated for hypertension. Patients may experience adverse reactions including dizziness, dry mouth, nausea, and hypokalemia. It is grouped under the following drug class(es): Diuretics. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Quinethazonum and Hydromox. Its PubChem CID is 6307.
Quinethazone
| CAS No | 73-49-4 |
|---|---|
| Molecular Formula | C10H12ClN3O3S |
| Molecular Weight | 289.74 g/mol |
| Synonyms | 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Quinethazone is a member of the class of quinazolines that is quinazolin-4-one substituted at positions 2, 6 and 7 by ethyl, sulfamoyl and chloro groups respectively; a thiazide-like diuretic used to treat hypertension.
The listed CAS number is 73-49-4.
The listed molecular formula is C10H12ClN3O3S.
The listed molecular weight is 289.74 g/mol.
7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide.
The source lists Quinethazonum and Hydromox.